Top 20 Algeta investors
The most complete profiles first. Showing 20 of 20.
Chris JacksonVerified
Venture Capital, Investor · United States
SeedHealth CareE-commerceWomen FoundedLife SciencePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Peter BainesVerified
Venture Capital, Investor · United Kingdom
SeedHealth CareE-commerceCybersecurityDeepTechPortfolio: Catalyst Biosciences, Vitrue, Am-Beo, Thiakis and 53 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Jason DoddVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Keith UnderwoodVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Per Samuelsson
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Staffan Lindstrand
Venture Capital, Private Equity Firm, Investor · Sweden
SeedHealth CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Nikki Matthews
Venture Capital · United States
Health CareWomen FoundedLife ScienceSoftwarePortfolio: Priothera, Spruce Biosciences, BONESUPPORT, Arpida AG and 54 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Contact details available
Contact details available
Staale Myrstad
Private Equity Firm · Norway
Health CareInvestment ManagementChemicalBiotechnologyPortfolio: Algeta
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Cytos16
- GenSight Biologics16
- Wilson Therapeutics16
- Spruce Biosciences16
- Oxagen11
- Avila Therapeutics11
- Pathwork Diagnostics11
- Avillion10
- Vaxcyte10
- Novexel10
- MD On-Line10
Frequently asked questions
How many Algeta investors are on Angel Roster?
Angel Roster lists 20 Algeta investors. 7 of them (35%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (9) and Advisor Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Algeta investors invest in?
Among those that list a stage, the most common are Series B (6) and Seed (4).
Where are Algeta investors based?
Most are based in the United States (9), the United Kingdom (6) and Sweden (3).
Which companies have Algeta investors backed?
The most-backed portfolio companies among them are Cytos (16), GenSight Biologics (16), Wilson Therapeutics (16), Spruce Biosciences (16) and Oxagen (11).
How do I contact Algeta investors?
Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.